Side effects of Immune Therapy using a Combination of ATG-MMF-Tacrolimus for Beta cellTransplantation in Non-Uremic Type 1 Diabetic Patients: 'Beta-cell Replacement - Do Patients benefit?'

P Gillard, Chantal Mathieu, L. Crenier, W Engelen, Zhidong Ling, Daniel Pipeleers, Bart Keymeulen

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)354-354
Number of pages1
JournalDiabetes Care
Volume54
Publication statusPublished - 2005

Keywords

  • TRANSPLANTATION

Cite this